Royalty Pharma plc (RPRX)
NASDAQ: RPRX · Real-Time Price · USD
39.55
-0.17 (-0.43%)
At close: Jan 16, 2026, 4:00 PM EST
39.92
+0.37 (0.94%)
After-hours: Jan 16, 2026, 7:42 PM EST
Royalty Pharma Market Cap
Royalty Pharma has a market cap or net worth of $22.83 billion as of January 16, 2026. Its market cap has increased by 101.42% in one year.
Market Cap
22.83B
Enterprise Value
30.84B
1-Year Change
101.42%
Ranking
Category
Stock Price
$39.55
Market Cap Chart
Since June 16, 2020, Royalty Pharma's market cap has increased from $15.76B to $22.83B, an increase of 44.85%. That is a compound annual growth rate of 6.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 16.90B | 2.36% |
| Dec 31, 2025 | 16.51B | 45.66% |
| Dec 31, 2024 | 11.33B | -9.30% |
| Dec 29, 2023 | 12.50B | -28.31% |
| Dec 30, 2022 | 17.43B | 1.85% |
| Dec 31, 2021 | 17.12B | -11.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 268.23B |